NexCAR19: India’s own CAR-T Cell Therapy
Central Idea India has achieved a significant milestone in the field of cancer treatment with the approval of NexCAR19, its first indigenous CAR-T Cell Therapy, by the Central Drugs Standard Control Organisation (CDSCO). Developed by ImmunoACT, an incubated company of IIT Bombay, NexCAR19 is set to transform cancer treatment in India and make it more… Continue reading NexCAR19: India’s own CAR-T Cell Therapy

